Skip to content

The effectiveness of transcranial Direct Current Stimulation of the brain (tDCS) among people with Depressive Disorder

The effectiveness of transcranial Direct Current Stimulation of the brain (tDCS) among people with Depressive Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015122525691N1
Enrollment
20
Registered
2016-04-28
Start date
2016-08-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder. This block contains disorders in which the fundamental disturbance is a change in affect or mood to depression (with or without associated anxiety) or to elation. The mood change is usually accompanied by a change in the overall level of activity

Interventions

Intervention 1: Intervention group: tDCS was administered with DC-stimulator. Twenty minutes of 2 mA anodal and cathodal tDCS was delivered via two conductive rubber electrodes encased in saline soak
Treatment - Devices
Intervention group: tDCS was administered with DC-stimulator. Twenty minutes of 2 mA anodal and cathodal tDCS was delivered via two conductive rubber electrodes encased in saline soaked sponges (surf
Control group: The sham procedure consisted of an initial 30s ramp-in phase of active stimulation and 30¬s a ramp-out phase.

Sponsors

Qom University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diagnose of major depressive disorder; age over 18 years; lack of co-morbid disorders in axis I and II. Exclusion criteria: Other axis I or II comorbidity; mental retardation; substance abuse or dependence ; heart disease; a history of seizures and epileps; treatment failure of ECT for the current period of depression; pregnancy; medication concurrent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The reduction in depression scores. Timepoint: Before treatment, after acute treatment, one month after the end of treatment. Method of measurement: Inventory.

Secondary

MeasureTime frame
The reduction in anxitey scores. Timepoint: Before treatment, after acute treatment, one month after the end of treatment. Method of measurement: Inventory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Rahmatinejad

Qom University of Medical Sciences

Rahmatinejadp@yahoo.com+98 21 8860 5323

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026